WebOct 4, 2024 · TrialSpark has built a technology platform that optimizes all aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. WebApr 13, 2024 · He has led investments in companies like Headway, Honor, Ramp, Rightway, Robinhood, and Trialspark, and was a part of the firm's investments in Affirm, Lemonade, and Oscar.
TrialSpark — 2 Investments, Performance analytics, Stats - Unicorn …
WebSep 30, 2024 · TrialSpark Inc. will fund its move into drug development with a $156 million financing round that closed earlier this year and values the company at more than $1 … WebFaster drug development through our proprietary tech-driven platform. Time savings of 1-3+ years per drug program. $1B+ sales advantage per drug program. Scaled technology and … oohposition
Startup with $120 million for deals aims to make drugs cheaply
WebTrialSpark acquires clinical-stage drugs from pharma and biotech and develops them faster, unlocking greater value per program and accelerating access to new treatments for patients. TrialSpark is backed by leading investors such as Sam Altman, Michael Moritz, Sequoia Capital, Thrive Capital, Dragoneer, Section 32, and John Doerr. WebJun 12, 2024 · TrialSpark does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and … WebJun 16, 2024 · Among the people he connected with was Benjamine Liu, the CEO and co-founder of TrialSpark, which has raised $87 million from investors including Sequoia Capital, Thrive Capital, and John Doerr. ooh production occupations